The sequence of the trimethoprim resistance gene of the 3.7-kb plasmid (pIP823) that confers high-level resistance (MIC, 1,024 g/ml) to Listeria monocytogenes BM4293 was determined. The gene was identical to dfrD recently detected in Staphylococcus haemolyticus MUR313. The corresponding protein, S2DHFR, represents the second class of high-level trimethoprim-resistant dihydrofolate reductase identified in gram-positive bacteria. We propose that trimethoprim resistance in L. monocytogenes BM4293 could originate in staphylococci.
Listeria monocytogenes is a gram-positive pathogen responsible for severe food-borne infections which can lead to spontaneous abortion in pregnant women and to meningitis, meningoencephalitis, and septicemia primarily in newborns, immunocompromised patients, and elderly people (12) . Firstchoice treatment of listeriosis generally consists of ampicillin combined with gentamicin or of co-trimoxazole (7, 11) . Since 1988, more than 80 strains of L. monocytogenes resistant to one or more antibiotics have been isolated from food, the environment, or patients with sporadic cases of listeriosis (2) .
Dihydrofolate reductase (DHFR) is a key enzyme in the tetrahydrofolic pathway, in which it catalyzes the NADPHdependent reduction of dihydrofolate to tetrahydrofolate (10) . Due to structural analogy with dihydrofolate, trimethoprim is a competitive inhibitor of this enzyme in bacteria (10) . The most common mechanism of resistance to trimethoprim is plasmidmediated production of an additional trimethoprim-resistant DHFR which can function in place of the susceptible host chromosomal enzyme. In gram-negative bacteria, a minimum of 17 different plasmid-encoded DHFRs have been described (10) . By contrast, only two types of DHFR that confer resistance to trimethoprim have been described in gram-positive bacteria. The type S1 enzyme encoded by the dfrA gene located in transposon Tn4003 has been found in Staphylococcus aureus, Staphylococcus haemolyticus, Staphylococcus epidermidis, and Staphylococcus hominis (3, 13) , and recently, the type S2 DHFR encoded by dfrD carried by plasmid pABU17 has been detected in S. haemolyticus MUR313 (4).
In a previous study, we described the first strain of L. monocytogenes (strain BM4293) resistant to high levels of trimethoprim (MIC, 1,024 g/ml). This strain, isolated from the environment in France, harbors plasmid pIP823, of 3.7 kb, which is responsible for the resistance (2) . Since the resistance determinant did not hybridize with a dfrA-specific probe (2), we decided to clone and sequence this new gene.
(Part of this work was presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy [1] .) Plasmid pIP823 DNA partially digested with Sau3A and pUC18 DNA digested with BamHI were mixed, ligated, and introduced by transformation into Escherichia coli DH5␣ (Gibco BRL, Eragny, France). Cloning was performed with restriction endonucleases (Pharmacia Biotech, Saclay, France), T4 DNA ligase (Pharmacia), and alkaline phosphatase (Pharmacia) by standard methods (14) . Transformants were selected on Mueller-Hinton agar (Sanofi Diagnostics Pasteur, Marnes-LaCoquette, France) containing 100 g of ampicillin (Laboratories Panpharma, Fougères, France) per ml and 5 g of trimethoprim (Roche, Fontenay-sous-Bois, France) per ml and were screened for their plasmid contents by agarose gel electrophoresis of crude bacterial lysates. The smallest recombinant plasmid, pAT460, was found to contain a 1.1-kb insert. E. coli LH18 thyA⌬fol::kan, from which the gene for DHFR has been deleted, is a mutant auxotroph for thymine which is thus unable to grow on Mueller-Hinton agar (9) . This strain, after acquisition of pAT460, was able to grow on Mueller-Hinton plates, whereas the same host containing pUC18 was not. This trans-complementation assay indicated that pAT460, which conferred resistance to the new host, encodes a functional DHFR.
The nucleotide sequence of both strands of the pAT460 insert was determined by the dideoxynucleotide chain-termination method (15) with T7-modified DNA polymerase (Sequenase; United States Biochemicals, Cleveland, Ohio), [␣- 486-bp sequence from the TTG codon at coordinate 560 to the TAA codon at coordinate 1046, designated dfrD, could code for a protein of 162 amino acid residues with a calculated molecular mass of 19,273 Da, designated S2DHFR. The GϩC content of dfrD (31.5%) was more similar to that of Staphylococcus DNA (34%) than to that of DNA from L. monocytogenes (38%) and Enterococcus (38%). The deduced amino acid sequence of type S2 DHFR encoded by pIP823 was aligned with those of known DHFRs in the SwissProt and GenBank databases by using the Genetics Computer Group program ( Fig. 1) (5, 8) . This sequence was found to be identical to that of the recently described S2DHFR encoded by dfrD of pABU17 from S. haemolyticus MUR313 (4). The two enzymes differ by their number of amino acid residues since the ATG translational initiation codon was chosen for the S2DHFR from S. haemolyticus. On the basis of the structural and kinetic properties, the active site of S2DHFR is very closely related to that of the resistant and susceptible DHFRs already described in staphylococci (3, 4, 13) . The S2DHFR was more distantly related to the S1DHFR from S. aureus, with 38.1% amino acid identity, and it showed less similarity with trimethoprim-resistant DHFRs from gram-negative bacteria (from 22.2% with type X DHFR to 37.7% with type IIIa DHFR).
In contrast to plasmid pABU17 (3.8 kb) from S. haemolyticus, plasmid pIP823 (3.7 kb) from L. monocytogenes does not possess a BamHI site, and the three EcoRI sites present in the two plasmids yield restriction fragments of different sizes (Fig.  2) . These plasmids therefore appear to be different. However, the 81-bp sequence upstream and the 203-bp sequence downstream from dfrD are identical in pIP823 and pABU17 (data not shown). Plasmid pIP823 is able to replicate and is stable in E. coli HB101 and S. aureus RN4220, where it confers highlevel trimethoprim resistance (2; data not shown). It is therefore likely that pIP823 belongs to the family of rolling-circle replicating plasmids, common in staphylococci, that possess a broad host spectrum including gram-positive and gram-negative bacteria (2, 6). Our results suggest that the trimethoprim resistance gene dfrD from L. monocytogenes BM4293 could originate in the genus Staphylococcus. However, it would be interesting to characterize the trimethoprim-susceptible chromosomal dfr gene of L. monocytogenes to obtain additional information on the origin of dfrD and on the divergence and the evolution of DHFRs from gram-positive bacteria. The emergence of trimethoprim resistance in L. monocytogenes is of particular interest since the trimethoprim-sulfamethoxazole combination is a successful alternative treatment for human listeriosis (7) . Dissemination of plasmid pIP823 from BM4293 to other strains of L. monocytogenes and to other species of Listeria is likely. Acquisition by L. monocytogenes of other resistance genes carried by this family of plasmids can also be anticipated.
Nucleotide sequence accession number. The nucleotide sequence of the pAT460 insert has been submitted to the GenBank database and has been given accession number U43152.
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